Matches in Wikidata for { <http://www.wikidata.org/entity/Q37466393> ?p ?o ?g. }
- Q37466393 description "article científic" @default.
- Q37466393 description "article scientifique" @default.
- Q37466393 description "articolo scientifico" @default.
- Q37466393 description "artigo científico" @default.
- Q37466393 description "artículu científicu espublizáu en 2014" @default.
- Q37466393 description "bilimsel makale" @default.
- Q37466393 description "scientific article published on February 2014" @default.
- Q37466393 description "vedecký článok" @default.
- Q37466393 description "vetenskaplig artikel" @default.
- Q37466393 description "videnskabelig artikel" @default.
- Q37466393 description "vědecký článek" @default.
- Q37466393 description "wetenschappelijk artikel" @default.
- Q37466393 description "wissenschaftlicher Artikel" @default.
- Q37466393 description "наукова стаття, опублікована в лютому 2014" @default.
- Q37466393 description "научни чланак" @default.
- Q37466393 description "مقالة علمية نشرت في فبراير 2014" @default.
- Q37466393 name "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy" @default.
- Q37466393 name "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy" @default.
- Q37466393 name "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy." @default.
- Q37466393 type Item @default.
- Q37466393 label "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy" @default.
- Q37466393 label "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy" @default.
- Q37466393 label "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy." @default.
- Q37466393 prefLabel "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy" @default.
- Q37466393 prefLabel "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy" @default.
- Q37466393 prefLabel "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy." @default.
- Q37466393 P1433 Q37466393-054DC6EE-4BC6-4CAE-899A-7DADEB5E75E1 @default.
- Q37466393 P1476 Q37466393-7AE0ABCA-3ACE-478F-9E0B-B11FCA99E175 @default.
- Q37466393 P2093 Q37466393-364D5BFF-1F89-4BFC-8F2B-9FA6D6D3B278 @default.
- Q37466393 P2093 Q37466393-5CAEA2BE-294C-432B-83CE-6F5E1C8CDCD1 @default.
- Q37466393 P2093 Q37466393-6B66D75E-0C97-4F09-9E45-9A1C9189AB7C @default.
- Q37466393 P2093 Q37466393-83AFFBB3-FFD8-4437-9533-4D93A8A2707E @default.
- Q37466393 P2093 Q37466393-8BC989E7-4267-446D-9806-D1E8D6A5B56C @default.
- Q37466393 P2093 Q37466393-9A1BEF23-82EA-4CA6-86B4-CA99F990A6D3 @default.
- Q37466393 P2093 Q37466393-B51A9FF8-6DF0-4110-A534-36F968930EAD @default.
- Q37466393 P2093 Q37466393-B6EAC4AA-7A20-4927-8113-7C41C69F99BE @default.
- Q37466393 P2093 Q37466393-B8FA09D1-214E-4A5C-B819-266141770288 @default.
- Q37466393 P2093 Q37466393-D2BB8790-EF18-4DB0-B2F1-4F0B9930F86E @default.
- Q37466393 P2093 Q37466393-D7A1492B-C3AE-4A0A-9937-304B857D0800 @default.
- Q37466393 P2093 Q37466393-EAE0A882-B169-4708-BF64-6FEA4F61A578 @default.
- Q37466393 P2093 Q37466393-ECACDEB7-5EBB-47DA-9D95-36B1E28CA94C @default.
- Q37466393 P2093 Q37466393-F47FD769-01F1-47F5-8BF0-07995EE0971D @default.
- Q37466393 P2093 Q37466393-F570703F-652E-4162-A443-D0B7633DB73B @default.
- Q37466393 P2093 Q37466393-FCA4678C-BCB7-4811-8DBE-8B8D6179356C @default.
- Q37466393 P2860 Q37466393-084ED52F-5764-4298-AFEA-1DACE9F4F2B5 @default.
- Q37466393 P2860 Q37466393-2A118FEF-209B-4026-80ED-F86C6E5C4AD1 @default.
- Q37466393 P2860 Q37466393-2BB4833B-5158-4AC6-AE14-847E197603A4 @default.
- Q37466393 P2860 Q37466393-3488E2F0-7952-4707-8705-58660D999CBA @default.
- Q37466393 P2860 Q37466393-3C78497E-D623-47E8-AD30-CAE6BD593F7C @default.
- Q37466393 P2860 Q37466393-422B6171-2726-4F8C-ADFE-BDC3B5D865EE @default.
- Q37466393 P2860 Q37466393-439DFF54-C82C-4C82-81F5-F6682476C234 @default.
- Q37466393 P2860 Q37466393-43DDB49E-22AE-404B-BB1A-FDEA2F0128D5 @default.
- Q37466393 P2860 Q37466393-5927060E-A417-4BA3-82E8-106E15D596F1 @default.
- Q37466393 P2860 Q37466393-658C4197-2594-4B7E-B2E6-DCEDFB37F64B @default.
- Q37466393 P2860 Q37466393-6920ECFA-0C6B-4A67-8E55-58446499E967 @default.
- Q37466393 P2860 Q37466393-6E3EA704-9F1C-4501-98EE-828BF1A3956B @default.
- Q37466393 P2860 Q37466393-780735D9-7496-4B16-A6B7-A74E1A0522A1 @default.
- Q37466393 P2860 Q37466393-81EF82EC-9A80-47FF-A4AC-D63DEC7EB760 @default.
- Q37466393 P2860 Q37466393-851F04CE-5A34-4639-9C55-B8787342AC27 @default.
- Q37466393 P2860 Q37466393-86087B3B-11F5-406C-927F-0EA231B27102 @default.
- Q37466393 P2860 Q37466393-96524213-A9BB-4AB8-A6D4-13C14597983C @default.
- Q37466393 P2860 Q37466393-A5E29C15-AD9D-47E1-B770-428747C2A93E @default.
- Q37466393 P2860 Q37466393-A65AD19C-F9A9-4F31-930D-6BE21A086FE9 @default.
- Q37466393 P2860 Q37466393-A975FBDE-89C9-4C48-8EE3-F8E7FEB0855F @default.
- Q37466393 P2860 Q37466393-AA0E615B-6BD1-4BC8-84C1-01370FCA9B75 @default.
- Q37466393 P2860 Q37466393-AEB3204C-F326-43DF-8A06-1E746AB8572B @default.
- Q37466393 P2860 Q37466393-B37DD14B-57CA-4ED3-BAC5-5A1C44571A16 @default.
- Q37466393 P2860 Q37466393-B40E3DF1-276B-4B72-B733-521C27A6AFDD @default.
- Q37466393 P2860 Q37466393-C083356E-C90C-4046-9D96-17F4A04C868A @default.
- Q37466393 P2860 Q37466393-C2141F7D-15A9-4031-8A5B-A98DBEE26BDE @default.
- Q37466393 P2860 Q37466393-C35F74D3-3A55-44B8-AD8C-74D27117DC2F @default.
- Q37466393 P2860 Q37466393-CC64230D-A425-4B29-973A-08AA2A919CAF @default.
- Q37466393 P2860 Q37466393-D16294EB-166E-45EB-808D-E6EEEC32124B @default.
- Q37466393 P2860 Q37466393-D983FC5C-B1E5-4162-9793-067047F16ACA @default.
- Q37466393 P2860 Q37466393-E0B3C0CE-BAEF-4E4D-890B-C349F4AEF8C7 @default.
- Q37466393 P2860 Q37466393-F0E5C94F-6C9F-4183-AA7B-87F925DAA270 @default.
- Q37466393 P2860 Q37466393-F8EE9B05-2C38-43AE-ADB2-0654D8B0126B @default.
- Q37466393 P2860 Q37466393-FBD8597B-7B78-41C7-8A53-072038EFEF51 @default.
- Q37466393 P304 Q37466393-2B27FBE2-ACA6-46BC-B434-89F4A25C9ABC @default.
- Q37466393 P31 Q37466393-5DA83F09-5621-4D14-BBDC-834FC2D22F53 @default.
- Q37466393 P356 Q37466393-07717416-44D6-465B-B916-8787A6D00081 @default.
- Q37466393 P433 Q37466393-DB04A926-211F-4798-989A-581A7F2F1420 @default.
- Q37466393 P478 Q37466393-87498335-8588-458C-B5AC-EF50D2725891 @default.
- Q37466393 P50 Q37466393-08CFF2E3-48AD-4B9C-A10E-73BB9442CC38 @default.
- Q37466393 P50 Q37466393-2C449A4B-AA76-4C43-9A84-8CDAF21F9723 @default.
- Q37466393 P50 Q37466393-66E66EF6-87DF-42B5-B81A-974FC20E840A @default.
- Q37466393 P577 Q37466393-22BCA46E-2596-47CD-AF9D-D64A8EE1ACED @default.
- Q37466393 P5875 Q37466393-72C90F81-2D42-4B5B-A215-6328ABE3EE0F @default.
- Q37466393 P698 Q37466393-0C5F4094-8F29-4572-9405-BA209C6DACAD @default.
- Q37466393 P921 Q37466393-09071035-48F4-4D72-AC01-F7EE6E21CFD8 @default.
- Q37466393 P921 Q37466393-191B7D06-9B03-47AE-B772-1D737FC5C872 @default.
- Q37466393 P921 Q37466393-20DCD4CC-DA07-470B-885A-4CA06C1CDD03 @default.
- Q37466393 P921 Q37466393-F563BFE9-F0E9-4741-BA3A-D6E4FAC01652 @default.
- Q37466393 P932 Q37466393-3988B694-E876-4C6F-B45B-105E3E719219 @default.
- Q37466393 P356 MUS.23904 @default.
- Q37466393 P698 23681940 @default.
- Q37466393 P1433 Q15764281 @default.
- Q37466393 P1476 "SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy" @default.
- Q37466393 P2093 "Bakri Elsheikh" @default.
- Q37466393 P2093 "Bernard LaSalle" @default.